Nutriband CEO Gareth Sheridan Named Finalist in 2025 EY Entrepreneur of the Year Awards
Nutriband CEO Gareth Sheridan named finalist in 2025 EY Entrepreneur of the Year Awards for leadership in transforming the company. AVERSA technology aims to prevent opioid patch misuse, highlighting a commitment to patient safety.
This news highlights the recognition of Nutriband's CEO for his leadership in the pharmaceutical industry and the company's innovative approach to addressing opioid abuse. The development of abuse-deterrent technology like AVERSA showcases a commitment to patient safety and responsible pain management.